key: cord-0916986-lg3121s2
authors: Khalili, Nastran; Haseli, Sara; Bahrami-Motlagh, Hooman; Keshavarz, Elham; Khalili, Neda; Langroudi, Taraneh Faghihi; Khameneh, Arash; Taheri, Morteza Sanei
title: Neurologic Involvement in COVID-19: Radiologists’ Perspective
date: 2020-05-05
journal: Acad Radiol
DOI: 10.1016/j.acra.2020.04.035
sha: f3bfe853d10167ee3850fed0dc5db967655b2c99
doc_id: 916986
cord_uid: lg3121s2

nan

mainly present with symptoms such as fever, dyspnea and cough (1). Neurologic manifestations, although relatively uncommon, also have been reported. According to published studies, the neurologic involvement of COVID-19 mainly falls into three categories: 1) central nervous system (CNS) involvement, such as dizziness, headache, impaired consciousness, acute cerebrovascular disease, and epilepsy, 2) peripheral nervous system involvement including anosmia, hypogeusia, visual impairment, and neuralgia and 3) skeletal muscle damage (2) . Acute Necrotizing Encephalopathy (ANE), a rare complication of viral infections that is associated with intracranial cytokine storm, was recently reported in a woman with COVID-19 in the US. The patient had presented with altered mental status and had subsequently undergone CT and MRI brain scans

Neurological symptoms are often insignificant and non-specific at the early stages of COVID-19 infection, increasing the risk of misdiagnosis and delayed management of patients (4) . Also, it has been shown that major neurologic events such as ischemic stroke and cerebral hemorrhage occur more frequently in patients with severe infection (2) . With disease progression, factors such as increased inflammatory cytokine production and impaired coagulation function increase the risk of cerebrovascular disease and subsequently, result in clinical deterioration and a higher mortality rate. Thus, early identification of patients with neurologic involvement is of high importance.

Obtaining a detailed medical history and physical examination, as well as performing imaging could help to detect neurologic manifestations in a timely manner. If a patient with suspected or proven COVID-19 presents with neurological signs or symptoms, emergency action should be taken by neurologists, radiologists, and infectious disease specialists in order to properly manage From another aspect, decontamination of imaging devices and suites should be considered.

Recently, the ACR published guidance on this issue (6), recommending that while cleaning and disinfection protocols are greatly dependent on the clinical circumstances of each individual setting, 60-minute downtime is generally required accompanied with cleaning of all at-reach surfaces in a particular pattern with approved disinfectant agents. (8, 9, 12) . It is important to note that the CT gantry is larger than the MRI gantry and thus, this may increase the possible contamination of the MR machine with COVID-19 patients' droplets. Whether CT scans or MR machines should be cleaned with different disinfectants has not been investigated yet in the COVID-19 pandemic, but studies have shown that applying 0.1% sodium hypochlorite or 62-71% ethanol on surfaces is sufficient (10, 11) . Hence, more information about cleaning MRI/CT scans in the current outbreak should be gathered ( Figure 2 ).

Conclusively, neuroimaging should be preserved only for patients at a high risk of developing serious neurologic events. Strict adherence to cleaning protocols is also recommended in radiologic centers to prevent the spread of infection. 

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study

COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features

Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists

ACR Guidance on COVID-19 and MR Use

Respirators and surgical facemasks for COVID-19: implications for MRI

ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for

ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection

Policies and Guidelines for COVID-19 Preparedness: Experiences from the University of Washington

Prevention and control measures in radiology department for COVID-19

Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents

COVID-19 protection guidelines in outpatient medical imaging centers. Academic Radiology